Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Daiichi Sankyo
McKesson
Johnson and Johnson
Harvard Business School
US Army
Mallinckrodt
QuintilesIMS
Colorcon

Generated: January 22, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Anti-Allergic Agents

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mk Labs DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 083087-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharm Intl DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 080592-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst PHENERGAN promethazine hydrochloride INJECTABLE;INJECTION 008857-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 202640-002 Sep 17, 2012 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 085146-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride SUPPOSITORY;RECTAL 040428-002 Mar 31, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Delcor Asset Corp PHENERGAN promethazine hydrochloride TABLET;ORAL 007935-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Citi
Cerilliant
Johnson and Johnson
Medtronic
Cantor Fitzgerald
Deloitte
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.